Clinica IMA
Adrogue, Buenos Aires, Argentina
General hospital in Adrogué
Francisco Seguí 593, B1846 Adrogué, Provincia de Buenos Aires
About Clinica IMA
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Clinica IMA
During the past decade, Clinica IMA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
2007-04-17
2030-04-30
Recruiting
1,200
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
2008-11-03
2022-11-30
Active, not recruiting
69
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
2009-08-25
2024-12-31
Active, not recruiting
137
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2010-02-05
2020-11-03
Completed
123
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
2010-04-14
2022-09-13
Completed
33
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
2011-01-01
2028-10-01
Active, not recruiting
252
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica IMA"
#1 collaborator was "Eucatech AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Clinica IMA
According to Clinical.Site data, the most researched conditions in "Clinica IMA" are
"Coronary Artery Disease" (1 trials), "Coronary Heart Disease" (1 trials) and "Coronary Restenosis" (1 trials). Many other conditions were trialed in "Clinica IMA" in a lesser frequency.
Clinical Trials Intervention Types at Clinica IMA
Most popular intervention types in "Clinica IMA" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bare Metal Stent" (1 trials), "Drug Eluting Stent" (1 trials), "Drug Eluting stent" (1 trials) and "Oral sirolimus" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica IMA
The vast majority of trials in "Clinica IMA" are
2 trials for "All" genders.
Clinical Trials Status at Clinica IMA
Currently, there are NaN active trials in "Clinica IMA".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Clinica IMA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinica IMA, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".